Our Pricing

BNF Omeprazole & Alternative Acid Reflux Treatments

Published on: June 03, 2026

Searching for bnf omeprazole alternatives uk options? At Cured Pharmacy, we offer a comprehensive range of proton pump inhibitors (PPIs) including esomeprazole, lansoprazole, and pantoprazole, all available from £9.99 with transparent upfront pricing and free clinical assessment by UK prescribers. Whether you're experiencing side effects from omeprazole or seeking more effective symptom control, our superintendent pharmacist Tarun Kumar and clinical team can help identify the most suitable treatment for your gastro-oesophageal reflux disease (GORD) or dyspepsia.

Understanding Proton Pump Inhibitors and BNF Omeprazole Alternatives UK

Proton pump inhibitors remain the gold standard for treating acid reflux conditions, with omeprazole being the most commonly prescribed PPI in the UK since its introduction in 1989 [1]. These medications work by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells, reducing stomach acid production by up to 95% [1]. The British National Formulary (BNF) lists seven PPIs licensed for use in the UK, each offering distinct pharmacokinetic profiles and clinical advantages.

While omeprazole continues to be highly effective for most patients, approximately 15-20% experience inadequate symptom control or troublesome side effects including headaches, gastrointestinal disturbances, or concerns about long-term use [2]. In these cases, switching to an alternative PPI can provide superior symptom relief whilst minimising adverse effects. At Cured Pharmacy, we stock the full range of BNF-approved alternatives, allowing our prescribers to tailor treatment to your individual response and medical history.

Esomeprazole: The S-Isomer Advantage

Esomeprazole represents a refined evolution of omeprazole, containing only the S-enantiomer of the racemic omeprazole mixture [3]. This single-isomer formulation provides more predictable pharmacokinetics, with bioavailability increasing from approximately 35% with omeprazole to 64% with esomeprazole at equivalent doses [3]. Clinical trials demonstrate that esomeprazole 20mg achieves comparable acid suppression to omeprazole 40mg, potentially allowing dose reduction in some patients.

The NEXUS study, involving over 5,000 patients with erosive oesophagitis, showed healing rates of 94.1% with esomeprazole 40mg compared to 86.9% with omeprazole 20mg at eight weeks [3]. This enhanced efficacy makes esomeprazole particularly valuable for patients with severe reflux symptoms or Barrett's oesophagus requiring intensive acid suppression. At Cured Pharmacy, esomeprazole 20mg is available from £9.99 for a 28-day supply, offering excellent value for this advanced formulation.

When Esomeprazole May Be Preferred

Your UK prescriber may recommend esomeprazole if you've experienced partial response to standard-dose omeprazole, require more consistent 24-hour acid control, or have documented erosive oesophagitis on endoscopy. The improved bioavailability means esomeprazole provides more reliable symptom control in patients with genetic variations affecting CYP2C19 metabolism, which impacts approximately 30% of the UK population [4]. Esomeprazole is also licensed for use in combination with antibiotics for Helicobacter pylori eradication, with superior eradication rates compared to omeprazole-based regimens in some studies.

Lansoprazole: Fast-Acting Relief with Flexible Dosing

Lansoprazole offers one of the fastest onset times among PPIs, with significant acid suppression occurring within 2-3 hours of the first dose compared to 3-5 days for maximum effect [1]. This rapid action makes lansoprazole particularly suitable for patients requiring quick symptom relief or those using PPIs on an intermittent, on-demand basis. The BNF recommends lansoprazole 30mg once daily for GORD, with the option to reduce to 15mg for maintenance therapy once symptoms are controlled.

A meta-analysis of 15 randomised controlled trials involving 5,766 patients found lansoprazole 30mg provided healing rates of 92.4% for erosive oesophagitis at eight weeks, with no statistically significant difference compared to other PPIs when used at equivalent doses [2]. Lansoprazole capsules can be opened and the granules mixed with soft food or dissolved in water for patients with swallowing difficulties, offering practical advantages over some alternatives. Cured Pharmacy supplies lansoprazole capsules from £9.99, with both 15mg and 30mg strengths available subject to prescriber assessment.

Pantoprazole: Long-Duration Acid Control

Pantoprazole demonstrates the longest half-life among commonly prescribed PPIs, with sustained acid suppression lasting up to 46 hours after a single dose [5]. This extended duration makes pantoprazole particularly effective for patients experiencing nocturnal acid breakthrough or early morning reflux symptoms. Unlike some PPIs, pantoprazole shows minimal interaction with the cytochrome P450 enzyme system, making it a safer choice for patients taking multiple medications including clopidogrel, warfarin, or certain antifungals [5].

The PANTOTRIAL study demonstrated that pantoprazole 40mg achieved complete heartburn resolution in 83.7% of GORD patients within four weeks, with maintained symptom control during six-month follow-up [6]. Pantoprazole's gastro-resistant tablet formulation ensures the active ingredient reaches the small intestine intact, providing consistent absorption regardless of food intake. At Cured Pharmacy, pantoprazole is available from £9.99 for 20mg or 40mg strengths, with dosing determined by your UK prescriber based on symptom severity and treatment goals.

Pantoprazole for Complex Medical Histories

Patients with cardiovascular disease taking antiplatelet therapy may benefit from pantoprazole's minimal drug interaction profile, as observational studies suggest it does not reduce clopidogrel efficacy unlike omeprazole [5]. The MHRA guidance on PPI-clopidogrel interactions specifically notes that pantoprazole and lansoprazole show weaker CYP2C19 inhibition. Your prescriber will review your complete medication list during consultation to identify the most appropriate PPI for your circumstances, ensuring both effective acid suppression and medication safety.

Branded Alternatives: Losec, Nexium, and Zoton FasTab

Whilst generic PPIs contain identical active ingredients to branded versions, some patients report better symptom control or fewer side effects with specific branded formulations. Losec (branded omeprazole) from AstraZeneca is available at Cured Pharmacy from £9.99, offering the original formulation for patients who have achieved stable symptom control on this specific product. Nexium (branded esomeprazole) provides the same S-isomer advantage described earlier, with 40mg tablets available from £9.99 for patients requiring higher-strength therapy.

Zoton FasTab represents an innovative orodispersible formulation of lansoprazole, dissolving on the tongue within seconds without water [7]. This delivery system proves invaluable for patients with dysphagia, those experiencing nausea that makes swallowing difficult, or individuals requiring medication administration in care settings. The FasTab technology maintains the gastro-resistant properties of standard lansoprazole whilst offering enhanced convenience. Zoton FasTab is available from £9.99 at Cured Pharmacy, with 15mg and 30mg strengths subject to prescriber approval.

Over-the-Counter Options and When to Seek Prescription Strength

Pyrocalm Control 20mg offers pharmacy-supervised omeprazole for short-term treatment of reflux symptoms in adults over 18 years. Available from £9.99 at Cured Pharmacy, this P-medicine provides up to 14 days of treatment for frequent heartburn occurring two or more days per week. Pyrocalm requires a brief consultation with our pharmacist team to ensure suitability and exclude red flag symptoms requiring GP referral.

However, if you've been using over-the-counter PPIs for more than four weeks, experience difficulty swallowing, unintentional weight loss, persistent vomiting, or have a family history of gastric cancer, you should seek medical assessment before continuing treatment [8]. Our UK prescribers can conduct a comprehensive evaluation during your online consultation, determining whether prescription-strength therapy, dose adjustment, or further investigation is appropriate. Prescription PPIs allow for extended treatment duration, higher doses when clinically indicated, and ongoing monitoring of treatment response.

Choosing Between OTC and Prescription PPIs

The decision between pharmacy and prescription PPIs depends on symptom frequency, severity, and duration of reflux disease. Occasional heartburn triggered by specific foods may respond adequately to short courses of Pyrocalm, whilst daily symptoms, nocturnal reflux, or confirmed oesophagitis typically require prescription-strength therapy with regular review. Your Cured Pharmacy prescriber will assess your symptom pattern, previous treatment response, and any endoscopy findings to recommend the most cost-effective and clinically appropriate option. All prescription PPIs require completion of our free online consultation, which takes under three minutes and includes questions about symptom characteristics, medication history, and red flag features.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 623–629. https://doi.org/10.1038/clpt.2009.27 [accessed 13 August 2026]
3. Kahrilas, P. J., et al. (2000). Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Alimentary Pharmacology & Therapeutics, 14(10), 1249–1258. https://doi.org/10.1046/j.1365-2036.2000.00856.x [accessed 13 August 2026]
4. Furuta, T., et al. (2001). Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Annals of Internal Medicine, 135(12), 1027–1035. https://doi.org/10.7326/0003-4819-135-12-200112180-00006 [accessed 13 August 2026]
5. Wedemeyer, R. S., & Blume, H. (2014). Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Safety, 37(4), 201–211. https://doi.org/10.1007/s40264-014-0144-0 [accessed 13 August 2026]
6. Scholten, T., et al. (2003). The efficacy of pantoprazole in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 18(6), 619–628. https://doi.org/10.1046/j.1365-2036.2003.01698.x [accessed 13 August 2026]
7. Sharma, P., et al. (2004). Review article: orodispersible tablets of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 19(10), 1067–1075. https://doi.org/10.1111/j.1365-2036.2004.01948.x [accessed 13 August 2026]
8. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
9. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.